// App-Quantinova.ai

Mo2034 : Reduced Expression of Colonic Mucosal IL-10 mRNA in Irritable Bowel Syndrome: a Meta-Analysis

Researchers

Presenter

  • Nima Rezaei

Principal Investigators

  • Arezoo Shafieyoun

  • Leyla Samii

  • Keith A. Sharkey

Medical Centers

  • Riley Park Maternity Clinic, Calgary, AB, Canada

  • Department of Physiology and Pharmacology, Snyder Institute for Chronic Diseases and Hotchkiss Brain Institute, University of Calgary, Calgary, AB, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Irritable Bowel Syndrome

Biomarkers

  • Interleukin 10

Drug/Treatment

  • Interleukin-10

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved